Properties (56)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
lung disease
|
| gptkbp:associated_with |
asbestosis
interstitial lung disease sarcoidosis |
| gptkbp:causedBy |
environmental factors
genetic factors idiopathic_causes |
| gptkbp:clinicalTrials |
ongoing studies
testing new therapies investigating biomarkers |
| gptkbp:community |
education for healthcare providers
increased awareness needed research funding required |
| gptkbp:community_service |
educational resources
support groups online forums |
| gptkbp:demographics |
increasing globally
more common in older adults affects both genders |
| gptkbp:diseaseResistance |
high-resolution CT scan
variable progression |
| gptkbp:emergencyServices |
mechanical ventilation
hospitalization for acute exacerbation intensive care unit care |
| gptkbp:events |
Pulmonary Fibrosis Awareness Month
|
| gptkbp:geneticDiversity |
associated genes
familial_pulmonary_fibrosis |
| gptkbp:goal |
improve quality of life
slow disease progression manage symptoms |
| https://www.w3.org/2000/01/rdf-schema#label |
pulmonary fibrosis
|
| gptkbp:impact |
lungs
pulmonary rehabilitation oxygen therapy antifibrotic medications |
| gptkbp:judgingCriteria |
clinical evaluation
biopsy lung function tests |
| gptkbp:personalLife |
regular exercise
healthy diet stress management quit smoking avoid pollutants |
| gptkbp:provides |
gptkb:American_Lung_Association
gptkb:Pulmonary_Fibrosis_Foundation |
| gptkbp:relatedPatent |
gptkb:pulmonary_hypertension
lung cancer respiratory failure |
| gptkbp:research_focus |
gene therapy
stem cell therapy new_antifibrotic_agents |
| gptkbp:riskManagement |
smoking
certain medications exposure to pollutants |
| gptkbp:symptoms |
shortness of breath
chronic cough |